Staphylococcus aureusstrains isolated from bovine mastitis: virulence, antibody production and protection from challenge in a mouse model
Open Access
- 1 March 2003
- journal article
- Published by Oxford University Press (OUP) in FEMS Immunology & Medical Microbiology
- Vol. 35 (2) , 99-106
- https://doi.org/10.1016/s0928-8244(02)00458-3
Abstract
Septic arthritis in mice was used as a model to evaluate the virulence of Staphylococcus aureus and coagulase-negative staphylococci (CNS) isolated from cases of bovine mastitis. In addition, the model was used to evaluate the cross protection elicited by heterologous antibodies. Mice were intramuscularly inoculated with serial bacterial doses of different strains of S. aureus or CNS, for virulence determination; they were monitored for arthritis, gangrene or death up to 20 days. Antibody response, cross reactivity and resistance to challenge were tested by subcutaneous inoculation with a low dose of one of the S. aureus or CNS strains followed by challenge with two S. aureus strains. S. aureusα-hemolysin isolate was the most virulent, followed by α+β-hemolysin and β-hemolysin isolates. The least virulent isolates were the non-hemolytic S. aureus strains but even they were more virulent than the CNS strains tested. Antibodies against three different S. aureus antigens were detected by the ELISA in all mice that were inoculated with the S. aureus strains but not in any of those with the CNS strains. Immunoblot test against various S. aureus strains as antigens showed high cross-reactivity among the S. aureus strains but only a slight similarity, restricted to the bands above 36 kDa, with the CNS sera. Low-dose inoculation of α or α+β strains before challenge with homologous and heterologous strains protected the mice, whereas the two β strains provided only partial protection. The inoculations of non-hemolytic S. aureus or the CNS strains did not elicit any protection. Our findings demonstrate that pre-exposure of mice to a low dose of certain S. aureus strains could provide protection and that the antibodies produced could have an important protective role.Keywords
This publication has 20 references indexed in Scilit:
- Possible virulence factors ofStaphylococcus aureusin a mouse septic modelFEMS Immunology & Medical Microbiology, 1999
- Current Perspectives on Detection of Staphylococcal EnterotoxinsJournal of Food Protection, 1997
- Field trial of a staphylococcal mastitis vaccine in dairy herds: clinical, subclinical and microbiological assessmentsAustralian Veterinary Journal, 1996
- A Field Trial with an Experimental Vaccine Against Staphylococcus aureus Mastitis in Cattle. 1. Clinical ParametersJournal of Dairy Science, 1994
- Vaccination against experimental staphylococcal mastitis in dairy heifersResearch in Veterinary Science, 1992
- The Genetics of Staphylococcal Toxins and Virulence FactorsPublished by Elsevier ,1990
- Evaluation of Protein A and a Commercial Bacterin as Vaccines Against Staphylococcus aureus Mastitis by Experimental ChallengeJournal of Dairy Science, 1985
- Evaluation of Attenuated, Live Staphylococcal Mastitis Vaccine in Lactating HeifersJournal of Dairy Science, 1984
- Staphylococcal Capsular Vaccine for Preventing Mastitis in Two Herds in GeorgiaJournal of Dairy Science, 1984
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976